AzTrials
AzTrials

Eating BehaviorNCT03241121

Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome

A study testing Time restricted feeding, Regular dietary advices and Eating patterns in people with Eating Behavior and Metabolic Syndrome, run by University of Lausanne Hospitals at 2 sites in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

SwissChronoFood - Study of eating patterns with a smartphone app and the metabolic effects of time restricted feeding in metabolic syndrome The purpose of this study is to assess eating patterns among teenagers and adults with a new method, going beyond the pen-and-paper food diaries, and to investigate whether time… Read more about this study

Who is it for?
Ages 12 years and olderHealthy volunteers can take part
Conditions the study is for
Eating Behavior, Metabolic Syndrome, Obesity
What is being tested?
Time restricted feeding, Regular dietary advices and Eating patterns
Could I receive a placebo?
No, everyone receives an active treatment
How many people
235 participants
Where
2 sitesSwitzerland
Study dates
29 Sep 2017to 31 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Key inclusion criteria for both observation and intervention phases (Part 1+2):

  • Age ≥ 12 years
  • Body mass index ≥ 20 kg/m2 and stable weight (previous 3 months) in adults; BMI ≥ 25th percentile in teenagers
  • Smartphone compatible with the app (iOS or Android systems)

Additional inclusion criteria for the intervention phase (Part 2):

  • Any component of the metabolic syndrome following the International Diabetes Federation consensus definition
  • Eating duration >14h during the observation phase

Additional inclusion criteria for the mechanistic study (Part 3):

  • Age 18-40 years, men and pre-menopausal women
  • BMI 30-40 kg/m2
  • In the fasting state (at least 8 hours)

Key exclusion criteria for both observation and intervention phases (Part 1+2):

  • Pregnant and breastfeeding women, plans for maternity during the study
  • Major illness/fever over the previous month, active cancer
  • Eating disorder, on a diet / weight management, prior bariatric surgery
  • Major mental illness, unable to give informed consent
  • Current shift work or travel abroad planned in the next month

Additional exclusion criteria for the intervention phase (Part 2):

  • Prior cardiovascular event
  • Major liver, gastrointestinal, renal or endocrine disorder, diabetes mellitus with hypoglycemic drug(s)
  • Major sleep disorder, centrally acting medication
  • Lipid lowering drug, hypoglycemic drug, medication affecting the gut

Additional exclusion criteria for the mechanistic study (Part 3):

  • Impaired glucose tolerance (pre-diabetes) or diabetes mellitus
  • Positive pregnancy test

Trial locations and contacts

2 sites in 1 country.

Switzerland2 sites
  • Inselspital, Klinik für Allgemeine Innere Medizin

    Bern, Canton of Bern, 3010

  • University Hospital of Lausanne (CHUV)

    Lausanne, 1011

Other trials in Switzerland

About this study

Official title: Study of Eating Patterns With a Smartphone App and the Metabolic Effects of Time Restricted Feeding (TRF) in the Metabolic Syndrome - An Open-label Randomized Controlled Trial of TRF vs Regular Dietary Advices

SwissChronoFood - Study of eating patterns with a smartphone app and the metabolic effects of time restricted feeding in metabolic syndrome

The purpose of this study is to assess eating patterns among teenagers and adults with a new method, going beyond the pen-and-paper food diaries, and to investigate whether time restricted feeding leads to weight loss, improvement in lipid and glucose metabolism in individuals with components of the metabolic syndrome

Read the detailed description

The prevalence of the metabolic syndrome (MS) is increasing worldwide, due to the progression of its different components (central obesity, elevated blood pressure, impaired glucose tolerance and dyslipidemia), as well as the often associated liver steatosis. One way to tackle the obesity epidemic is to intervene early at the onset in childhood and teenage years - before cardio-metabolic complications have occurred. However, lifestyle programs targeting this age group had limited success in the current obesogenic environment. In particular, weight loss is a key factor in controlling all MS components, yet it is difficult to maintain over time.

Time restricted feeding (TRF) is an approach that emphasizes energy intake limited to certain windows of time within the 24-hour cycle without restrictions on calories or macronutrients. This has emerged as an appealing approach to reduce body weight while improving lipid profile and glucose metabolism. However, TRF has been mostly studied in animals and long-term prospective data on its efficacy and mechanisms in humans is lacking.

Prior to the intervention, the investigators will assess the eating patterns of participants with an innovative smartphone application ('app') which is less intrusive and more reliable than food diaries/questionnaires to assess eating behavior and patterns.

In this project, the investigators will assess eating patterns among teenagers and adults, and investigate whether a controlled TRF intervention leads to beneficial changes in MS components. Study Part 1 uses an epidemiological approach to establish baseline daily eating behavior, physical activity patterns and sleeping habits over 2 weeks (teenagers) and 4 weeks (adults) using the smartphone app. Those individuals meeting criteria for at least one component of MS and who have eaten for >14 hours per 24-hour cycle will be recruited for Study Part 2. In Part 2, participants will be assigned to TRF or active control groups, and followed in this pragmatic randomized controlled trial for 6 weeks (teenagers) and 6 months (adults) to assess the change in their weight and MS components, as well as liver fat deposits. Study Part 3 will investigate the underlying mechanisms of improved metabolic profile with TRF.

Being tested
Time restricted feeding, Regular dietary advices, Eating patterns
Keywords
Time Restricted Feeding, Eating patterns
Medical subject headings
Feeding Behavior, Metabolic Syndrome, Obesity, Dyslipidemias, Glucose Intolerance, Fatty Liver, Intermittent Fasting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Time restricted feedingBehavioural

    To eat only during a self-selected window of 12 hours, with no advice on nutrition quality, quantity or caloric intake

  • Regular dietary advicesBehavioural

    Regular dietary advices by a trained dietitian or research nurse according to current nutrition guidelines

  • Eating patternsDevice

    Data collection on eating patterns via the smartphone app

Study groups in NCT03241121
Study groupRoleWhat they receive
Time restricted feedingExperimentalFor those in the intervention phase (Part 2)
Receives: Behavioral: Time restricted feeding; Device: Eating patterns
Regular dietary advicesActive comparatorFor those in the intervention phase (Part 2)
Receives: Behavioral: Regular dietary advices; Device: Eating patterns

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Eating duration

    Duration from the first to last caloric intake over 24-hour cycle, collected via the smartphone app.

    Note: Key inclusion criterion for the intervention phase (Part 2).

    Measured: From baseline visit to end of observation phase (Part 1: 4 weeks for adults, 2 weeks for teenagers)

  2. Change of metabolic syndrome components

    Number of participants with changes in weight and/or lipid profile and/or glucose metabolism in the intervention phase (Part 2).

    Note: Changes of the different components will be analyzed separately as secondary outcomes.

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

Secondary outcomes (11)
  1. Adherence to TRF intervention

    After allocation to the TRF arm, assessment of the adherence to the intervention, as measured by eating duration from the first to last caloric intake over 24-hour cycle.

    Measured: From randomization visit to close-out visit (Part 2: 6 months for adults, 6 weeks for teenagers)

  2. Weight change

    Part of the composite primary outcome in the intervention phase (Part 2)

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  3. Change in lipid profile

    Part of the composite primary outcome in the intervention phase (Part 2)

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  4. Change in glucose metabolism

    Part of the composite primary outcome in the intervention phase (Part 2)

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  5. Change in blood pressure

    Systolic and diastolic blood pressure

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  6. Change in hepatic steatosis / fibrosis score

    As measured by the Fibroscan device

    Measured: From randomization visit to close-out visit (Part 2: 6 months for adults, 6 weeks for teenagers)

  7. Change in number of meals per day

    Temporal analysis of caloric intake events collected by the smartphone app

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  8. Change in meal intervals

    Temporal analysis of caloric intake events collected by the smartphone app

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  9. Change in fraction of calories consumed after noon

    Estimation of caloric content from food pictures collected by the smartphone app

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  10. Change in fraction of calories consumed after 6pm

    Estimation of caloric content from food pictures collected by the smartphone app

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

  11. Change in eating pattern difference between weekdays and weekends

    Indirect assessment of different lifestyle habits during weekdays and weekends

    Measured: From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2017
  2. Study start29 Sep 2017
  3. Primary completion31 Mar 2021
  4. Study completion31 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Study Part 1: Prospective longitudinal observational study. Study Part 2/3: Open-label randomized controlled trial.
Masking
None (open label)
Enrolment
235 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03241121
Sponsor's protocol ID
2017-00487
Other IDs
PZ00P3-167826, SSED-YI 2017, 2017
Status last verified
Aug 2024
First submitted
2 Apr 2017
Last updated
6 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymized dataset of selected variables that underlie results in a publication. Some data may not be amenable to complete anonymization and will not be shared to ensure appropriate confidentiality of participant's data.

Publications

  • Buso G, Favre L, Vionnet N, Gonzalez-Rodriguez E, Hans D, Puder JJ, Dubath C, Eap CB, Raffoul W, Collet TH, Mazzolai L. Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema. Obes Facts. 2022;15(6):762-773. doi: 10.1159/000527138. Epub 2022 Oct 28.

    PubMed 36310013
  • Phillips NE, Mareschal J, Schwab N, Manoogian ENC, Borloz S, Ostinelli G, Gauthier-Jaques A, Umwali S, Gonzalez Rodriguez E, Aeberli D, Hans D, Panda S, Rodondi N, Naef F, Collet TH. The Effects of Time-Restricted Eating versus Standard Dietary Advice on Weight, Metabolic Health and the Consumption of Processed Food: A Pragmatic Randomised Controlled Trial in Community-Based Adults. Nutrients. 2021 Mar 23;13(3):1042. doi: 10.3390/nu13031042.

    PubMed 33807102
  • Borloz S, Bucher Della Torre S, Collet TH, Jotterand Chaparro C. Consumption of Ultraprocessed Foods in a Sample of Adolescents With Obesity and Its Association With the Food Educational Style of Their Parent: Observational Study. JMIR Pediatr Parent. 2021 Nov 15;4(4):e28608. doi: 10.2196/28608.

    PubMed 34779776
  • Papageorgiou M, Biver E, Mareschal J, Phillips NE, Hemmer A, Biolley E, Schwab N, Manoogian ENC, Gonzalez Rodriguez E, Aeberli D, Hans D, Pot C, Panda S, Rodondi N, Ferrari SL, Collet TH. The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial. Obesity (Silver Spring). 2023 Feb;31 Suppl 1(Suppl 1):85-95. doi: 10.1002/oby.23577. Epub 2022 Oct 14.

    PubMed 36239695

Questions about this trial

What is this clinical trial studying?

A study testing Time restricted feeding, Regular dietary advices and Eating patterns in people with Eating Behavior and Metabolic Syndrome, run by University of Lausanne Hospitals at 2 sites in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Eating duration (time frame: From baseline visit to end of observation phase (Part 1: 4 weeks for adults, 2 weeks for teenagers)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03241121, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2024; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in